1-(4-tert-butylphenyl)propan-2-one | CAS:81561-77-5

We serve 1-(4-tert-butylphenyl)propan-2-one CAS:81561-77-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-(4-tert-butylphenyl)propan-2-one

Chemical Name:1-(4-tert-butylphenyl)propan-2-one
CAS.NO:81561-77-5
Synonyms:1-(4-tert-butylphenyl)propan-2-one
4-t-butylphenylacetone
1-(4-tert-butylphenyl)-2-propanone
1-[4-(1,1-dimethylethyl)phenyl]-2-propanone
p-tert-butylphenylacetone
2-Propanone,1-[4-(1,1-dimethylethyl)phenyl]
 
Physical and Chemical Properties:
Molecular Formula C13H18O
Molecular Weight 190.28100
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Fenpropimorph(CAS:67306-03-0).



Contact us for information like 1-(4-tert-butylphenyl)propan-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Propanone,1-[4-(1,1-dimethylethyl)phenyl] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Propanone,1-[4-(1,1-dimethylethyl)phenyl] Use and application,2-Propanone,1-[4-(1,1-dimethylethyl)phenyl] technical grade,usp/ep/jp grade.


Related News: This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine.4-Piperidin-4-ylmorpholine manufacturer The new restrictions on foreign nationals begin on February 3, Prime Minister Jacinda Ardern announced in a press release Sunday.2,5-Difluoro-4-iodopyridine supplier Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.Mesitaldehyde vendor AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.Social media users — including numerous medical experts — questioned whether the findings were supported by clinical evidence from treating coronavirus patients.